Studies show that overexposure of CD15 and B7-H6 ligands present on the cancer cells to their activating receptors DNAX accessory molecule-1 (DNAM-1) and Natural Killer Protein-30 (NKp30) leads to NK impairment [108]. This evidence concerns the gene CD226 and cancer.